The News Feed

Geographic atrophy

AMD Genetic Profile Predictive of Early GA Enlargement

ARMS2/HTRA1 is an important risk factor for identifying eyes likely to experience fast lesion progression.
September 19, 2023

New GA Drug from Iveric Bio Approved

Clinical trials show Izervay can slow disease progression with as few as six monthly doses.
August 7, 2023

Novel Microperimetry Endpoints Better at Detecting Functional Decline in GA

The metrics could lead to future clinical trials that better characterize both the natural history of the disease as well as early treatment response, the authors suggest.
June 16, 2023

The World According to GARPED

Study finds GA patients with a reabsorbed PED have significant visual deficits and may not benefit from new treatments aimed at inhibiting the complement system, as the mechanism is different.
June 1, 2023

cRORA Area on SD-OCT Shows Potential Utility as GA Parameter

The measurement was comparable to that shown on FAF in this study. Dispersion pattern and baseline lesion size may also predict enlargement rate.
May 17, 2023